The epidemiology, diagnosis and treatment of COVID-19

被引:528
作者
Zhai, Pan [1 ]
Ding, Yanbing [1 ]
Wu, Xia [2 ]
Long, Junke [3 ]
Zhong, Yanjun [4 ]
Li, Yiming [5 ]
机构
[1] Hubei Prov Hosp Tradit Chinese Med, Dept Neurol, Wuhan 430073, Hubei, Peoples R China
[2] Hubei Prov Hosp Tradit Chinese Med, Dept Resp Med, Wuhan 430073, Hubei, Peoples R China
[3] Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha 410011, Hunan, Peoples R China
[4] Cent South Univ, Xiangya Hosp 2, ICU Ctr, Changsha 41001, Hunan, Peoples R China
[5] Wuhan Univ, Dept Crit Care Med, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
COVID-19; Pandemic; Diagnosis; Isolation; Remdesivir; Clinical trials; CORTICOSTEROID TREATMENT; VIRAL-INFECTIONS; SPIKE PROTEIN; CHLOROQUINE; PNEUMONIA; CHINA; WUHAN; COV; AUTOMATION; REMDESIVIR;
D O I
10.1016/j.ijantimicag.2020.105955
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In December 2019, the outbreak of the novel coronavirus disease (COVID-19) in China spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 infection causes clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus. Human-to-human transmission via droplets, contaminated hands or surfaces has been described, with incubation times of 2-14 days. Early diagnosis, quarantine, and supportive treatments are essential to cure patients. This paper reviews the literature on all available information about the epidemiology, diagnosis, isolation and treatments of COVID-19. Treatments, including antiviral agents, chloroquine and hydroxychloroquine, corticosteroids, antibodies, convalescent plasma transfusion and vaccines, are discussed in this article. In addition, registered trials investigating treatment options for COVID-19 infection are listed. (C) 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页数:13
相关论文
共 90 条
[1]   Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe [J].
Agnandji, S. T. ;
Huttner, A. ;
Zinser, M. E. ;
Njuguna, P. ;
Dahlke, C. ;
Fernandes, J. F. ;
Yerly, S. ;
Dayer, J. -A. ;
Kraehling, V. ;
Kasonta, R. ;
Adegnika, A. A. ;
Altfeld, M. ;
Auderset, F. ;
Bache, E. B. ;
Biedenkopf, N. ;
Borregaard, S. ;
Brosnahan, J. S. ;
Burrow, R. ;
Combescure, C. ;
Desmeules, J. ;
Eickmann, M. ;
Fehling, S. K. ;
Finckh, A. ;
Goncalves, A. R. ;
Grobusch, M. P. ;
Hooper, J. ;
Jambrecina, A. ;
Kabwende, A. L. ;
Kaya, G. ;
Kimani, D. ;
Lell, B. ;
Lemaitre, B. ;
Lohse, A. W. ;
Massinga-Loembe, M. ;
Matthey, A. ;
Mordmueller, B. ;
Nolting, A. ;
Ogwang, C. ;
Ramharter, M. ;
Schmidt-Chanasit, J. ;
Schmiedel, S. ;
Silvera, P. ;
Stahl, F. R. ;
Staines, H. M. ;
Strecker, T. ;
Stubbe, H. C. ;
Tsofa, B. ;
Zaki, S. ;
Fast, P. ;
Moorthy, V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17) :1647-1660
[2]   Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus [J].
Angel Martinez, Miguel .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
[3]  
[Anonymous], 2020, Radiology, DOI DOI 10.1148/RADIOL.2020200642
[4]  
[Anonymous], EMERGING INFECT DIS
[5]   Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome [J].
Arabi, Yaseen M. ;
Mandourah, Yasser ;
Al-Hameed, Fahad ;
Sindi, Anees A. ;
Almekhlafi, Ghaleb A. ;
Hussein, Mohamed A. ;
Jose, Jesna ;
Pinto, Ruxandra ;
Al-Omari, Awad ;
Kharaba, Ayman ;
Almotairi, Abdullah ;
Al Khatib, Kasim ;
Alraddadi, Basem ;
Shalhoub, Sarah ;
Abdulmomen, Ahmed ;
Qushmaq, Ismael ;
Mady, Ahmed ;
Solaiman, Othman ;
Al-Aithan, Abdulsalam M. ;
Al-Raddadi, Rajaa ;
Ragab, Ahmed ;
Balkhy, Hanan H. ;
Al Harthy, Abdulrahman ;
Deeb, Ahmad M. ;
Al Mutairi, Hanan ;
Al-Dawood, Abdulaziz ;
Merson, Laura ;
Hayden, Frederick G. ;
Fowler, Robert A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (06) :757-767
[6]   Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020 [J].
Backer, Jantien A. ;
Klinkenberg, Don ;
Wallinga, Jacco .
EUROSURVEILLANCE, 2020, 25 (05) :10-15
[7]   Presumed Asymptomatic Carrier Transmission of COVID-19 [J].
Bai, Yan ;
Yao, Lingsheng ;
Wei, Tao ;
Tian, Fei ;
Jin, Dong-Yan ;
Chen, Lijuan ;
Wang, Meiyun .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14) :1406-1407
[8]   Real-Time Sequence-Validated Loop-Mediated Isothermal Amplification Assays for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) [J].
Bhadra, Sanchita ;
Jiang, Yu Sherry ;
Kumar, Mia R. ;
Johnson, Reed F. ;
Hensley, Lisa E. ;
Ellington, Andrew D. .
PLOS ONE, 2015, 10 (04)
[9]   Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities [J].
Biot, C ;
Daher, W ;
Chavain, N ;
Fandeur, T ;
Khalife, J ;
Dive, D ;
De Clercq, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (09) :2845-2849
[10]   Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens [J].
Chan, Jasper Fuk-Woo ;
Yip, Cyril Chik-Yan ;
To, Kelvin Kai-Wang ;
Tang, Tommy Hing-Cheung ;
Wong, Sally Cheuk-Ying ;
Leung, Kit-Hang ;
Fung, Agnes Yim-Fong ;
Ng, Anthony Chin-Ki ;
Zou, Zijiao ;
Tsoi, Hoi-Wah ;
Choi, Garnet Kwan-Yue ;
Tam, Anthony Raymond ;
Cheng, Vincent Chi-Chung ;
Chan, Kwok-Hung ;
Tsang, Owen Tak-Yin ;
Yuen, Kwok-Yung .
JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (05)